Citation Impact
Citing Papers
Acquired Immunity to Malaria
2009
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
2008
Discovery, mechanisms of action and combination therapy of artemisinin
2009 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
2008
Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores
2017
Leishmaniasis
2018 Standout
Quinolines and structurally related heterocycles as antimalarials
2010 Standout
Neglected tropical diseases
2009 Standout
Expression and substrate specificity of a recombinant cysteine proteinase B of Leishmania braziliensis
2008 StandoutNobel
The current status of zoonotic leishmaniases and approaches to disease control
2005
Domestic dog ownership: a risk factor for human infection with Leishmania (viannia) species
2003
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in Peru
2005
The biology and control of Phlebotomine sand flies
1999
Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis
2000
Successful Treatment of Drug‐Resistant Cutaneous Leishmaniasis in Humans by Use of Imiquimod, an Immunomodulator
2001
Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study
2001
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Operational strategies to achieve and maintain malaria elimination
2010
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
2005
COVID-19: A promising cure for the global panic
2020 Standout
Cutaneous leishmaniasis
2007 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity
1995
Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
2014
Effective clearance of intracellular Leishmania majorin vivo requires Pten in macrophages
2008 StandoutNobel
The global distribution and burden of dengue
2013 StandoutNature
Global malaria mortality between 1980 and 2010: a systematic analysis
2012 Standout
Malaria
2013 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007
2010
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused byLeishmania braziliensisin Peru and Bolivia
2015
Metabolism study and biological evaluation of bosentan derivatives
2016
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity
2015
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas
2008
Influence ofLeishmania (Viannia)Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis
2007
IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and Adaptation to a Rapid Diagnostic Test
2014
Molecular epidemiology and diagnosis of Leishmania: what have we learnt from genome structure, dynamics and function?
2002
The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future
2009
The past, present and future of anti-malarial medicines
2019
Leishmaniasis
1999 Standout
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry
2016 Standout
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI
2009 Standout
Evaluation of tert‐Butyl Isosteres: Case Studies of Physicochemical and Pharmacokinetic Properties, Efficacies, and Activities
2015
Dynamics of Malaria Drug Resistance Patterns in the Amazon Basin Region following Changes in Peruvian National Treatment Policy for Uncomplicated Malaria
2009
Single crystal X-ray structural features of aromatic compounds having a pentafluorosulfuranyl (SF5) functional group
2016
Contribution of Organofluorine Compounds to Pharmaceuticals
2020 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery
2013 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement
2017
The Neotropical Leishmania species: a brief historical review of their discovery, ecology and taxonomy
2010 Standout
Good Partnership between Sulfur and Fluorine: Sulfur-Based Fluorination and Fluoroalkylation Reagents for Organic Synthesis
2014
Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules
2012
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Advances in leishmaniasis
2005 Standout
Overcoming Drug Resistance to Heme-Targeted Antimalarials by Systematic Side Chain Variation of 7-Chloro-4-aminoquinolines
2008
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
Unsymmetrical Diaryl Sulfones through Electrochemical Oxidation of Fast Violet B in the Presence of Aryl Sulfinic Acids
2016
Insecticide-treated bed nets and curtains for preventing malaria
2004 Standout
Photoredox Catalysis in Organic Chemistry
2016 Standout
4-N-, 4-S-, and 4-O-Chloroquine Analogues: Influence of Side Chain Length and Quinolyl Nitrogen pKa on Activity vs Chloroquine Resistant Malaria
2008
Applications of Fluorine in Medicinal Chemistry
2015 Standout
CF2H, a Hydrogen Bond Donor
2017 Standout
The epidemiology and control of leishmaniasis in Andean countries
2000
Drug Resistance in Leishmaniasis
2006 Standout
Minisci reactions: Versatile CH-functionalizations for medicinal chemists
2011
Recent advancements in the synthesis of pentafluorosulfanyl (SF5)-containing heteroaromatic compounds
2017
Preparation and Utility of Organic Pentafluorosulfanyl-Containing Compounds
2014
Catalytic Asymmetric Synthesis of Thiols
2014 StandoutNobel
Works of Norma Roncal being referenced
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community
2005
Short report: detection of Leishmaniavirus in human biopsy samples of leishmaniasis from Peru.
1998
Cutaneous Leishmaniasis in the Peruvian Andes: Factors Associated with Variability in Clinical Symptoms, Response to Treatment, and Parasite Isolation Rate
1997
Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine
2009
Natural infections of Leishmania peruviana in animals in the Peruvian Andes
1999
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
2014
Lutzomyia verrucarum can transmit Leishmania peruviana, the aetiological agent of Andean cutaneous leishmaniasis
1993
POLYMORPHISM OF THE PLASMODIUM FALCIPARUM MULTIDRUG RESISTANCE AND CHLOROQUINE RESISTANCE TRANSPORTER GENES AND IN VITRO SUSCEPTIBILITY TO AMINOQUINOLINES IN ISOLATES FROM THE PERUVIAN AMAZON
2004
Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening
2007
Targeting the Fatty Acid Biosynthesis Enzyme, β-Ketoacyl−Acyl Carrier Protein Synthase III (PfKASIII), in the Identification of Novel Antimalarial Agents
2009
MULTIPLE HYBRID GENOTYPES OF LEISHMANIA (VIANNIA) IN A FOCUS OF MUCOCUTANEOUS LEISHMANIASIS
2007